Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioCardia, Inc.BCDA · Entity 7752 | Director · President and CEO | September 29, 2026 | October 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioCardia, Inc.
Report date September 29, 2026 · Filed October 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 384,885 |
Reported balance
After 2026-09-29 transaction · row 1
1 source rowRow 1 · 2026-09-29 · Purchase · Acquired 1,000 · Balance 384,885 F1: This transaction was executed in multiple trades ranging from $1.02 to $1.05 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades ranging from $1.02 to $1.05 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 23, 2025 Filed Apr 26, 2025 01:35 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 26,246 | $1.91 | $49,998.63 |
DisclosureSEC source: 0001437749-25-013196 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,966 F1 · shares: On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. Read SEC document |
| April 15, 2025 Filed Apr 17, 2025 23:44 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 100 | $2.14 | $214.00 |
DisclosureSEC source: 0001437749-25-012314 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,720 Read SEC document |
| April 11, 2025 Filed Apr 14, 2025 23:41 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 300 | $2.03 | $609.00 |
DisclosureSEC source: 0001437749-25-011966 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,620 F2 · shares: This transaction was executed in multiple trades ranging from $1.98 to $2.03 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F2 · price: This transaction was executed in multiple trades ranging from $1.98 to $2.03 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| April 10, 2025 Filed Apr 14, 2025 23:41 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 300 | $1.99 | $597.00 |
DisclosureSEC source: 0001437749-25-011966 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,320 F1 · shares: This transaction was executed in multiple trades ranging from $1.94 to $1.99 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $1.94 to $1.99 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| April 07, 2025 Filed Apr 8, 2025 21:01 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 500 | $1.96 | $980.00 |
DisclosureSEC source: 0001437749-25-011432 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,020 F1 · shares: This transaction was executed in a single for $1.96 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in a single for $1.96 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| April 04, 2025 Filed Apr 7, 2025 21:10 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 800 | $2.04 | $1,632.00 |
DisclosureSEC source: 0001437749-25-011212 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,520 F1 · shares: This transaction was executed in multiple trades ranging from $2.01 to $2.09 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $2.01 to $2.09 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| April 03, 2025 Filed Apr 4, 2025 01:08 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,200 | $2.24 | $2,688.00 |
DisclosureSEC source: 0001437749-25-010953 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,620 F1 · shares: This transaction was executed in multiple trades ranging from $2.19 to $2.55 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $2.19 to $2.55 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| April 03, 2025 Filed Apr 4, 2025 21:04 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 600 | $2.20 | $1,320.00 |
DisclosureSEC source: 0001437749-25-011045 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,720 F2 · shares: This transaction was executed in multiple trades ranging from $2.15 to $2.29 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F2 · price: This transaction was executed in multiple trades ranging from $2.15 to $2.29 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 21:04 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 500 | $2.23 | $1,115.00 |
DisclosureSEC source: 0001437749-25-011045 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,120 F1 · shares: This transaction was executed in multiple trades ranging from $2.16 to $2.28 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $2.16 to $2.28 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 13:30 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 500 | $2.11 | $1,055.00 |
DisclosureSEC source: 0001437749-25-006016 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,420 F1 · shares: This transaction was executed in multiple trades ranging from $2.05 to $2.15 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $2.05 to $2.15 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 22:42 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 600 | $2.48 | $1,488.00 |
DisclosureSEC source: 0001437749-25-003441 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,920 F1 · shares: This transaction was executed in multiple trades ranging from $2.37 to $2.50 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $2.37 to $2.50 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 01:36 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 239 | $2.38 | $568.82 |
DisclosureSEC source: 0001437749-25-002318 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,320 F2 · shares: This transaction was executed in multiple trades ranging from $2.36 to $2.41 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price F2 · price: This transaction was executed in multiple trades ranging from $2.36 to $2.41 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 01:36 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 500 | $2.40 | $1,200.00 |
DisclosureSEC source: 0001437749-25-002318 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,081 F1 · shares: This transaction was executed in a single trade at $2.40 per share. The price reported above reflects the weighted average per share sales price F1 · price: This transaction was executed in a single trade at $2.40 per share. The price reported above reflects the weighted average per share sales price Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 19:30 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,000 | $2.06 | $2,060.00 |
DisclosureSEC source: 0001437749-24-038364 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,581 Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 22:04 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 250 | $2.22 | $555.00 |
DisclosureSEC source: 0001437749-24-036997 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,581 F1 · shares: This transaction was executed in multiple trades ranging from $2.17 to $2.24 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $2.17 to $2.24 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 13:00 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,350 | $1.87 | $2,524.50 |
DisclosureSEC source: 0001437749-24-035685 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,331 F1 · shares: This transaction was executed in a single trade at $1.87 per share. F1 · price: This transaction was executed in a single trade at $1.87 per share. Read SEC document |
| October 11, 2024 Filed Oct 17, 2024 01:56 UTC | BioCardia, Inc. BCDA · Entity 7752 | Tax withholdingCommon Stock | 21,680 | $2.65 | $57,452.00 |
DisclosureSEC source: 0001437749-24-031412 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,981 F2 · shares: The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on October 11, 2024 and does not represent a sale by the Reporting Person. F2 · price: The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on October 11, 2024 and does not represent a sale by the Reporting Person. Read SEC document |
| October 11, 2024 Filed Oct 17, 2024 01:56 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantCommon Stock | 44,250 | $2.65 | $117,262.50 |
DisclosureSEC source: 0001437749-24-031412 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,661 F1 · shares: The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on October 11, 2024. F1 · price: The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on October 11, 2024. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 16:40 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantWarrant (right to buy) · Derivative | 41,666 | Not disclosed Strike: $3.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-028509 · rdgdoc.xml · derivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,666 Underlying: Common Stock · 41,666 shares Expires 2029-09-03 F1 · shares: These shares were purchased from the Issuer in a public offering that closed on September 3, 2024, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · price: These shares were purchased from the Issuer in a public offering that closed on September 3, 2024, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · derivative.underlying_shares: These shares were purchased from the Issuer in a public offering that closed on September 3, 2024, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 16:40 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantCommon Stock | 41,666 | $3.00 | $124,998.00 |
DisclosureSEC source: 0001437749-24-028509 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,411 F1 · price: These shares were purchased from the Issuer in a public offering that closed on September 3, 2024, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:12 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 300 | $3.05 | $915.00 |
DisclosureSEC source: 0001437749-24-021960 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,745 F2 · price: This transaction was executed in multiple trades ranging from $3.00 to $3.07 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:12 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 200 | $2.99 | $598.00 |
DisclosureSEC source: 0001437749-24-021960 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,445 F1 · price: This transaction was executed in multiple trades ranging from $2.99 to $3.00 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| June 21, 2024 Filed Jun 24, 2024 12:46 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 500 | $3.29 | $1,645.00 |
DisclosureSEC source: 0001437749-24-021033 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,245 F1 · price: This transaction was executed in multiple trades ranging from $3.24 to $3.29 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| June 14, 2024 Filed Jun 17, 2024 11:00 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 500 | $3.52 | $1,760.00 |
DisclosureSEC source: 0001437749-24-020431 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,745 Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 11:00 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 1,000 | $3.36 | $3,360.00 |
DisclosureSEC source: 0001437749-24-020012 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,245 F1 · price: This transaction was executed in multiple trades ranging from $3.31 to $3.40 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| April 19, 2024 Filed Apr 19, 2024 21:38 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 2,750 | $0.37 | $1,012.83 |
DisclosureSEC source: 0001437749-24-012590 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 558,697 Read SEC document |
| March 28, 2024 Filed Mar 28, 2024 23:33 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 500 | $0.39 | $195.00 |
DisclosureSEC source: 0001437749-24-009892 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 555,947 Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 12:00 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseWarrant (right to buy · Derivative | 54,054 | Not disclosed Strike: $0.44 | Not disclosed |
DisclosureSEC source: 0001437749-24-004265 · rdgdoc.xml · derivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,538 Underlying: Common Stock · 54,054 shares Expires 2026-02-13 F1 · shares: On February 13, 2024, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each two shares of common stock purchased. F1 · price: On February 13, 2024, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each two shares of common stock purchased. F1 · derivative.underlying_shares: On February 13, 2024, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each two shares of common stock purchased. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 12:00 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 108,108 | $0.46 | $49,999.95 |
DisclosureSEC source: 0001437749-24-004265 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 555,447 F1 · shares: On February 13, 2024, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each two shares of common stock purchased. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 00:13 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 4,000 | $0.87 | $3,484.00 |
DisclosureSEC source: 0001437749-23-024106 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 447,339 F1 · shares: This transaction was executed in multiple trades ranging from $0.858 to $0.880 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 17:30 UTC Amendment | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 4,000 | $0.87 | $3,484.00 |
DisclosureSEC source: 0001437749-23-024141 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 447,339 F1 · shares: This transaction was executed in multiple trades ranging from $0.858 to $0.880 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| August 14, 2023 Filed Aug 14, 2023 21:09 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 4,500 | $0.88 | $3,978.00 |
DisclosureSEC source: 0001437749-23-023755 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443,339 F1 · shares: This transaction was executed in multiple trades ranging from $0.883 to $0.884 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| August 14, 2023 Filed Aug 18, 2023 17:30 UTC Amendment | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 4,500 | $0.88 | $3,978.00 |
DisclosureSEC source: 0001437749-23-024140 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443,339 F1 · shares: This transaction was executed in multiple trades ranging from $0.883 to $0.884 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| June 23, 2023 Filed Jun 27, 2023 00:32 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 6,421 | $2.34 | $14,999.46 |
DisclosureSEC source: 0001437749-23-018553 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 438,839 F1 · shares: These shares were purchased from the issuer in a registered direct offering that closed on June 23, 2023. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 22:23 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | Tax withholdingCommon Stock | 36,821 | $1.77 | $65,173.17 |
DisclosureSEC source: 0001437749-23-016521 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 432,418 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on May 18, 2023 and does not represent a sale by the Reporting Person. Read SEC document |
| May 26, 2023 Filed May 30, 2023 21:01 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 6,200 | $1.60 | $9,920.00 |
DisclosureSEC source: 0001437749-23-016147 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 469,239 F1 · shares: This transaction was executed in multiple trades ranging from $1.54 to $1.92 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| May 18, 2023 Filed May 23, 2023 01:30 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantStock Option (right to buy) · Derivative | 159,723 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001437749-23-015515 · rdgdoc.xml · derivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,723 Underlying: Common Stock · 159,723 shares Expires 2033-05-18 F2 · derivative.exercise_date: The option vests and becomes exercisable as to 1/48th of the shares on June 18, 2023, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| May 18, 2023 Filed May 23, 2023 01:30 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 109,324 | $1.70 | $185,850.80 |
DisclosureSEC source: 0001437749-23-015515 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 463,039 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on May 18, 2023. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 13:01 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 14,880 | $1.68 | $24,998.40 |
DisclosureSEC source: 0001437749-22-029316 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,827 F1 · shares: These shares were purchased from the Issuer in a private placement that closed on December 16, 2022. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 21:00 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 1,400 | $1.86 | $2,604.00 |
DisclosureSEC source: 0001437749-22-027254 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,947 F2 · shares: This transaction was executed in multiple trades ranging from $1.85 to $1.89 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 21:00 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 3,100 | $1.87 | $5,797.00 |
DisclosureSEC source: 0001437749-22-027254 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,547 F1 · shares: This transaction was executed in multiple trades ranging from $1.83 to $1.92 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| September 23, 2022 Filed Sep 26, 2022 11:02 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 1,400 | $1.87 | $2,618.00 |
DisclosureSEC source: 0001437749-22-023018 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,447 F2 · shares: This transaction was executed in multiple trades ranging from $1.84 to $1.91 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 11:02 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 3,100 | $1.81 | $5,611.00 |
DisclosureSEC source: 0001437749-22-023018 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,047 F1 · shares: This transaction was executed in multiple trades ranging from $1.76 to $1.87 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 23:11 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 2,750 | $1.92 | $5,280.00 |
DisclosureSEC source: 0001437749-22-022935 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,947 F1 · shares: This transaction was executed in multiple trades ranging from $1.91 to $1.93 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| June 10, 2022 Filed Jun 13, 2022 21:12 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 4,500 | $1.46 | $6,570.00 |
DisclosureSEC source: 0001437749-22-014899 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,197 F1 · shares: This transaction was executed in multiple trades ranging from $1.43 to $1.49 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| May 13, 2022 Filed May 13, 2022 22:32 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 2,698 | $1.38 | $3,723.24 |
DisclosureSEC source: 0001437749-22-012420 · rdgdoc.xml · nonDerivative · entry 3 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,143 F3 · price: This transaction was executed in multiple trades ranging from $1.32 to $1.45 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 13, 2022 Filed Apr 14, 2023 23:52 UTC Amendment | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 3,498 | $1.37 | $4,792.26 |
DisclosureSEC source: 0001437749-23-010355 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 348,943 F1 · shares: The original Form 4 filed on May 13, 2022 incorrectly reported that 2,698 shares were purchased. 3,498 shares were purchased on May 13, 2022 and are correctly reported herein. F2 · shares: This transaction was executed in multiple trades ranging from $1.32 to $1.45 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F2 · price: This transaction was executed in multiple trades ranging from $1.32 to $1.45 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F3 · balance_after: The original Form 4 incorrectly reported that 348,143 shares were beneficially owned following the reported transaction. The corrected amount is reported herein. Read SEC document |
| May 12, 2022 Filed May 13, 2022 22:32 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | PurchaseCommon Stock | 11,302 | $1.20 | $13,562.40 |
DisclosureSEC source: 0001437749-22-012420 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,445 F2 · price: This transaction was executed in multiple trades ranging from $1.13 to $1.40 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 12, 2022 Filed May 19, 2022 00:03 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | Tax withholdingCommon Stock | 31,446 | $1.32 | $41,508.72 |
DisclosureSEC source: 0001437749-22-012954 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,697 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on April 14, 2022 and does not represent a sale by the Reporting Person. Read SEC document |
| May 12, 2022 Filed Apr 7, 2023 20:44 UTC Amendment | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | Tax withholdingCommon Stock | 26,458 | $1.32 | $34,924.56 |
DisclosureSEC source: 0001437749-23-009765 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 321,685 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connections with the net settlement of RSUs vested on April 14, 2022, and does not represent a sale by the reporting person. F2 · shares: The original Form 4 incorrectly reported that 31,446 shares had been withheld due to a clerical error. The corrected number is reported herein. F3 · balance_after: The original Form 4 incorrectly reported that 316,697 shares were beneficially owned following the reported transaction. The corrected amount is reported herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.